11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
暂无分享,去创建一个
Jeremy W Tomlinson | M. Cooper | G. Lavery | M. Hewison | E. Walker | P. Stewart | I. Bujalska | J. Tomlinson | Paul M Stewart | Mark S Cooper | Martin Hewison | Iwona J Bujalska | Gareth G Lavery | Elizabeth A Walker | Nicole Draper | N. Draper | Gareth G. Lavery | M. Hewison | M. S. Cooper | J. Tomlinson | E. A. Walker | Paul M. Stewart | P. Stewart
[1] Balme Hw. Adrenal Steroids and Disease , 1965 .
[2] P. Stewart,et al. Isoforms of 11β-hydroxysteroid dehydrogenase in human granulosa-lutein cells , 1997, Molecular and Cellular Endocrinology.
[3] M. Quinkler,et al. 11β-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids , 2002 .
[4] R. Alzamora,et al. Role of 11β-Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries , 2000 .
[5] R. Jilka,et al. Sex steroids and bone. , 2002, Recent progress in hormone research.
[6] R. Dullaart,et al. Lack of relationship between 11β‐hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients * , 2000, Clinical endocrinology.
[7] T. Remer,et al. Adrenocortical activity in healthy children is associated with fat mass. , 2003, The American journal of clinical nutrition.
[8] C. Edwards,et al. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. , 1995, Endocrinology.
[9] M. Hewison,et al. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. , 1999, The Journal of endocrinology.
[10] H. Bradlow,et al. Influence of thyroid function on the in vivo cortisol ⇌ cortisone equilibrium in man , 1983 .
[11] T. Saruta,et al. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. , 1986, The Journal of clinical endocrinology and metabolism.
[12] C. Tortorella,et al. In vivo evidence that human adrenal glands possess 11 beta-hydroxysteroid dehydrogenase activity. , 1999, Life sciences.
[13] P. Murray,et al. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. , 2001, Investigative ophthalmology & visual science.
[14] J. Stegeman,et al. A possible role for microsomal hexose-6-phosphate dehydrogenase in microsomal electron transport and mixed-function oxygenase activity. , 1979, Biochemical and biophysical research communications.
[15] K. Dong,et al. Cloning and expression of the 11β-hydroxysteroid dehydrogenase type 1 gene in the baboon 1 Note: This work was supported by NIH Research Grant R01 HD-13294. 1 , 1997, Molecular and Cellular Endocrinology.
[16] B. Egan,et al. Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings. , 1996, Hypertension.
[17] S. Shalet,et al. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. , 2000, The Journal of clinical endocrinology and metabolism.
[18] A. Boulton,et al. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity. , 1999, The Journal of clinical endocrinology and metabolism.
[19] B. Walker,et al. Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 , 1997 .
[20] A. Howie,et al. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts , 1995, Molecular and Cellular Endocrinology.
[21] W. Drake,et al. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. , 2001, The Journal of clinical endocrinology and metabolism.
[22] A J Howie,et al. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. , 1998, The Journal of clinical endocrinology and metabolism.
[23] P. White,et al. 11 beta-hydroxysteroid dehydrogenase. , 1993, Vitamins and hormones.
[24] B. Murphy. Cortisol production and inactivation by the human lung during gestation and infancy. , 1978, The Journal of clinical endocrinology and metabolism.
[25] M. Hewison,et al. Characterization of 11 â-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines , 1999 .
[26] J. Mason,et al. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. , 1995, The Journal of clinical endocrinology and metabolism.
[27] A. López Bernal,et al. Corticosteroid metabolism in vitro by human placenta, fetal membranes and decidua in early and late gestation. , 1981, Placenta.
[28] R. Thieringer,et al. Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[29] B. Walker,et al. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. , 2001, The Journal of clinical endocrinology and metabolism.
[30] B. Waddell,et al. Immunolocalization of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 in Rat Uterus: Variation Across the Estrous Cycle and Regulation by Estrogen and Progesterone. , 1998, Endocrinology.
[31] P. McDonough,et al. Steroid, follicle-stimulating hormone, and luteinizing hormone profiles in identical twins with polycystic ovaries. , 1972, American journal of obstetrics and gynecology.
[32] H. Woitge,et al. Cloning and in Vitro Characterization ofα 1(I)-Collagen 11β-Hydroxysteroid Dehydrogenase Type 2 Transgenes as Models for Osteoblast-Selective Inactivation of Natural Glucocorticoids. , 2001, Endocrinology.
[33] B. Khalid,et al. Differential regulation of the oxidative 11β-hydroxysteroid dehydrogenase activity in testis and liver☆ , 2000, Steroids.
[34] G. Hammond,et al. Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. , 1992, Endocrinology.
[35] B. Cooke,et al. Leukocytes modulate 11β-hydroxysteroid dehydrogenase (11β-HSD) activity in human granulosa-lutein cell cultures , 1997, Molecular and Cellular Endocrinology.
[36] N. Sakura,et al. Failure of cortisone acetate therapy in 21‐hydroxylase deficiency in early infancy , 2001, Pediatrics International.
[37] K. Yang,et al. Co-expression of two distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine placenta , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[38] P. Stewart,et al. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. , 1993, Endocrinology.
[39] S. Hillier,et al. Regulation of 11beta-hydroxysteroid dehydrogenase isoforms and glucocorticoid receptor gene expression in the rat uterus. , 1999, The Journal of endocrinology.
[40] K. Yang,et al. Evidence for distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine liver and kidney , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[41] L. Skálová,et al. Reduction of the Potential Anticancer Drug Oracin in the Rat Liver In‐vitro , 2000, The Journal of pharmacy and pharmacology.
[42] M. Hardy,et al. Glucocorticoid induces apoptosis in rat leydig cells. , 2002, Endocrinology.
[43] A. C. Maiyar,et al. Glucocorticoid-stimulated CCAAT/enhancer-binding protein alpha expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells , 1996, Molecular and cellular biology.
[44] H. Schriefers,et al. The hormonal regulation of hepatic microsomal 11beta-hydroxysteroid dehydrogenase activity in the rat. , 1978, Acta endocrinologica.
[45] G. Rook,et al. Pathogenetic role, in human and murine tuberculosis, of changes in the peripheral metabolism of glucocorticoids and antiglucocorticoids , 1997, Psychoneuroendocrinology.
[46] M. Hewison,et al. 11β-Hydroxysteroid dehydrogenases, cell proliferation and malignancy , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[47] M. Cooper,et al. Prereceptor regulation of glucocorticoid action by 11β‐hydroxysteroid dehydrogenase: a novel determinant of cell proliferation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] J. Whitworth,et al. THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN , 1989, Clinical endocrinology.
[49] G. Phillipov,et al. Apparent cortisone reductase deficiency: a unique form of hypercortisolism. , 1996, The Journal of clinical endocrinology and metabolism.
[50] T. Olsson,et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. , 2002, The Journal of clinical endocrinology and metabolism.
[51] C. Edwards,et al. Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene. , 1992, Molecular endocrinology.
[52] O. Muneyyirci-Delale,et al. Characterization of 11β-hydroxysteroid dehydrogenase of human placenta: Evidence for the existence of two species of 11β-hydroxysteroid dehydrogenase , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[53] C. Edwards,et al. 11 beta-Hydroxysteroid dehydrogenase mRNA expression in rat kidney. , 1991, The American journal of physiology.
[54] L. Abrahmsén,et al. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. , 2003, Endocrinology.
[55] I. Miyamori,et al. Decreased activity of 11 beta-hydroxysteroid dehydrogenase in mesenteric arteries of Dahl salt-sensitive rats. , 1994, Life sciences.
[56] J. Hynes,et al. Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo. , 1995, Endocrine research.
[57] M. Hardy,et al. Identification of a Kinetically Distinct Activity of 11β-Hydroxysteroid Dehydrogenase in Rat Leydig Cells. , 1997, Endocrinology.
[58] D. Morris,et al. Selective inhibition of sheep kidney 11β-hydroxysteroid dehydrogenase isoform 2 activity by 5α-reduced (but not 5β) derivatives of adrenocorticosteroids , 1997, Steroids.
[59] K. Sheppard,et al. 11β-Hydroxysteroid Dehydrogenase 1 Transforms 11-Dehydrocorticosterone into Transcriptionally Active Glucocorticoid in Neonatal Rat Heart. , 2002, Endocrinology.
[60] A. Wallace,et al. MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11Β-HYDROXYSTEROID DEHYDROGENASE DEFFICIENCY COMES OF AGE , 1987 .
[61] J. Funder,et al. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. , 1989, Endocrinology.
[62] M. Cooper,et al. Glucocorticoid activity, inactivity and the osteoblast. , 1999, The Journal of endocrinology.
[63] R. Prough,et al. Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. , 2003, Molecular pharmacology.
[64] M. Hardy,et al. 11 beta-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. , 1994, Endocrinology.
[65] C. Monder,et al. Purification and Characterization of the Corticosteroid 1lβ-Dehydrogenase Component of the Rat Liver 1lβ-Hydroxysteroid Dehydrogenase Complex* , 1988 .
[66] C. Cope,et al. The Production Rate of Cortisol in Man , 1958, British medical journal.
[67] S. Hillier,et al. An anti-inflammatory role for glucocorticoids in the ovaries? , 1998, Journal of reproductive immunology.
[68] P. Curtis,et al. Direct inhibition of ovarian steroidogenesis by Cortisol and the modulatory role of 11β‐hydroxysteroid dehydrogenase , 1993, Clinical endocrinology.
[69] C. Byrne,et al. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. , 2002, Diabetes.
[70] H. Endou,et al. Glucose dehydrogenase (hexose 6-phosphate dehydrogenase) and the microsomal electron transport system. Evidence supporting their possible functional relationship. , 1979, Journal of biochemistry.
[71] C. Edwards,et al. 11β-hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulated , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[72] B. Walker,et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. , 2000, Endocrinology.
[73] T. Mune,et al. Mutations in putative glycosylation sites of rat 11 beta-hydroxysteroid dehydrogenase affect enzymatic activity. , 1995, Biochimica et biophysica acta.
[74] J. Seckl,et al. 11 â-Hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells , 1998 .
[75] C. V. van Noorden,et al. Sex-specific biotransformation and detoxification after xenobiotic exposure of primary cultured hepatocytes of European flounder (Platichthys flesus L.). , 2002, Aquatic toxicology.
[76] B. Walker,et al. Effects of the 11β-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes , 2003 .
[77] D. Ray,et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency , 2003, Nature Genetics.
[78] C. Grossmann,et al. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. , 2000, European journal of endocrinology.
[79] M Krook,et al. Characteristics of short-chain alcohol dehydrogenases and related enzymes. , 1991, European journal of biochemistry.
[80] J. Funder,et al. Specific nuclear localization of 11-dehydrocorticosterone in rat colon: evidence for a novel corticosteroid receptor. , 1996, Endocrinology.
[81] Y. Deshaies,et al. PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. , 2003, Diabetes.
[82] P. Björntorp,et al. Cortisol secretion in relation to body fat distribution in obese premenopausal women. , 1992, Metabolism: clinical and experimental.
[83] F. Frey,et al. Tumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol Shuttle , 1997, The Journal of experimental medicine.
[84] Margaret S. Wu,et al. PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver , 2000 .
[85] M. Hewison,et al. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. , 2002, The Journal of clinical endocrinology and metabolism.
[86] B. Walker,et al. Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11&bgr;-Hydroxysteroid Dehydrogenase , 2001, Circulation.
[87] C. Edwards,et al. Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. , 1989, Endocrinology.
[88] C. Edwards,et al. Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. , 1993, Endocrinology.
[89] B. McEwen,et al. Regional distribution of 11 beta-hydroxysteroid dehydrogenase in rat brain. , 1991, Endocrinology.
[90] R. Anderson,et al. Differential expression of messenger ribonucleic acids encoding 11beta-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells. , 1997, The Journal of clinical endocrinology and metabolism.
[91] C. Elkan,et al. Hidden Markov model analysis of motifs in steroid dehydrogenases and their homologs. , 1997, Biochemical and biophysical research communications.
[92] F. Anderson,et al. Inactivation of corticosteroids in intestinal mucosa by 11 beta-hydroxysteroid: NADP oxidoreductase (EC 1.1.1.146). , 1983, The American journal of gastroenterology.
[93] R. Siegel,et al. In vitro metabolism of cortisol by human abdominal adipose tissue. , 1982, Journal of steroid biochemistry.
[94] B. Walker,et al. Glucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[95] J. Flier,et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. , 2003, The Journal of clinical investigation.
[96] J. Flier,et al. A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.
[97] R. Dilley,et al. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation. , 2003, Endocrinology.
[98] L. M. Thurston,et al. Expression of 11beta-hydroxysteroid dehydrogenase (11betaHSD) proteins in luteinizing human granulosa-lutein cells. , 2003, The Journal of endocrinology.
[99] D. Molnár,et al. Urinary cortisol to cortisone metabolites in hypertensive obese children , 2000, Journal of endocrinological investigation.
[100] C. Shackleton,et al. Apparent Cortisone Reductase Deficiency: A Rare Cause of Hyperandrogenemia and Hypercortisolism , 2000, Hormone Research in Paediatrics.
[101] M. Baker,et al. Unusual evolution of 11β‐ and 17β‐hydroxysteroid and retinol dehydrogenases , 1996, Bioessays.
[102] E. Maser,et al. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen. , 2003, Chemico-biological interactions.
[103] J. Jenkins. The metabolism of cortisol by human extra-hepatic tissues. , 1966, The Journal of endocrinology.
[104] T. Mune,et al. 11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess , 1997 .
[105] S. G. Haider,et al. Trends of Reproductive Hormones in Male Rats During Psychosocial Stress: Role of Glucocorticoid Metabolism in Behavioral Dominance1 , 2002, Biology of reproduction.
[106] L. M. Thurston,et al. Expression of 11 -hydroxysteroid dehydrogenase (11 HSD) proteins in luteinizing human granulosa–lutein cells , 2003 .
[107] M. Korbonits,et al. Expression of 11β-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors , 2001 .
[108] C. Shackleton,et al. 11β-Hydroxysteroid dehydrogenase: Fact or fancy? , 1984, Steroids.
[109] J. Gustafsson,et al. Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. , 2002, Diabetes.
[110] H. J. Harris,et al. Intracellular Regeneration of Glucocorticoids by 11β-Hydroxysteroid Dehydrogenase (11β-HSD)-1 Plays a Key Role in Regulation of the Hypothalamic-Pituitary-Adrenal Axis: Analysis of 11β-HSD-1-Deficient Mice1 , 2001 .
[111] E. Maser,et al. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. , 1995, Biochemical pharmacology.
[112] R. Kletzien,et al. Glucose‐6‐phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue‐specific regulation by hormones, nutrients, and oxidant stress , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[113] M. W. Khalil,et al. Metyrapone is a competitive inhibitor of 11β-hydroxysteroid dehydrogenase type 1 reductase , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[114] R. Sapolsky,et al. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. , 2000, Endocrine reviews.
[115] B. Jessen,et al. Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts. , 2002, Gene.
[116] J. Seckl,et al. Foetal Lung Maturation in 11β-Hydroxysteroid Dehydrogenase Type 1 Knockout Mice , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[117] D. Hales,et al. Glucocorticoid-mediated repression of P450scc mRNA and de novo synthesis in cultured Leydig cells. , 1989, Endocrinology.
[118] S. Ralston. Genetic control of susceptibility to osteoporosis. , 2002, The Journal of clinical endocrinology and metabolism.
[119] Y. J. Liu,et al. Sex-specific effects of growth hormone on hepatic 11beta-hydroxysteroid dehydrogenase activity and gene expression in hypothyroid rats. , 1997, Life sciences.
[120] A. Blum,et al. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: additional domains for membrane attachment? , 2001, Chemico-biological interactions.
[121] E. Canalis,et al. 11β‐Hydroxysteroid Dehydrogenase, an Amplifier of Glucocorticoid Action in Osteoblasts , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[122] B. Walker,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: 11�-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action* , 2000 .
[123] D. Berliner,et al. 11 beta-Hydroxy dehydrogenase system activity in thymi of mice following prolonged cortisol treatment. , 1960, Endocrinology.
[124] D. Morris,et al. 11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat. , 1996, Hypertension.
[125] Z. Krozowski,et al. Expression of the 11β-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[126] M. Cintorino,et al. Human endometrial decidual cell-associated 11 beta-hydroxysteroid dehydrogenase expression: its potential role in implantation. , 1997, Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy.
[127] S. Lye,et al. Effects of cortisol and oestradiol on hepatic 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor proteins in late-gestation sheep fetus. , 2003, The Journal of endocrinology.
[128] P. Wood,et al. Relationship between ovarian cortisol:cortisone ratios and the clinical outcome of in vitro fertilization and embryo transfer (IVF‐ET) , 1999, Clinical endocrinology.
[129] R. Clayton,et al. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. , 1994, The New England journal of medicine.
[130] O. Pedersen,et al. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. , 2002, The Journal of clinical endocrinology and metabolism.
[131] C. Edwards,et al. 'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. , 1994, Journal of molecular endocrinology.
[132] L. Skálová,et al. Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1. , 2003, Chemico-biological interactions.
[133] P. He,et al. Intracrine Induction of 11β-Hydroxysteroid Dehydrogenase Type 1 Expression by Glucocorticoid Potentiates Prostaglandin Production in the Human Chorionic Trophoblast1 , 2002, Biology of reproduction.
[134] H. Hauner,et al. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. , 1987, The Journal of clinical endocrinology and metabolism.
[135] S. Yamamoto,et al. Expression of 11 -hydroxysteroid dehydrogenases in bovine follicle and corpus luteum , 2003 .
[136] P. White,et al. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. , 1989, The Journal of biological chemistry.
[137] R. Thieringer,et al. Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity* , 2001, The Journal of Biological Chemistry.
[138] M. Devoto,et al. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. , 2001, Human molecular genetics.
[139] M. Quinkler,et al. Evidence for isoforms of 11 beta-hydroxysteroid dehydrogenase in the liver and kidney of the guinea pig. , 1997, Journal of Endocrinology.
[140] J. Seckl,et al. Tissue- and temporal-specific regulation of 11β-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[141] B. Strutt,et al. Expression of Steroid-Converting Enzymes in Osteoblasts Derived from Rat Vertebrae , 2002, Osteoporosis International.
[142] K. Noonan,et al. The effect of growth hormone replacement therapy on cortisol–cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β‐hydroxysteroid dehydrogenase activity , 1998, Clinical endocrinology.
[143] J. Funder,et al. Substrate and inhibitor specificity of the cloned human 11 beta-hydroxysteroid dehydrogenase type 2 isoform. , 1996, The American journal of physiology.
[144] D. Granner,et al. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. , 1984, The Journal of biological chemistry.
[145] R. Winston,et al. Increased follicular fluid total and free cortisol levels during the luteinizing hormone surge. , 1997, Fertility and sterility.
[146] J. Hofman,et al. The Effect of Pretreatment of Saliva on Steroid Hormone Concentrations , 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[147] A. Leung,et al. Glucocorticoids stimulate plasminogen activator production by rat granulosa cells. , 1989, Endocrinology.
[148] M. Hewison,et al. Functional Expression, Characterization, and Purification of the Catalytic Domain of Human 11-β-Hydroxysteroid Dehydrogenase Type 1* , 2001, The Journal of Biological Chemistry.
[149] J. Weaver,et al. Sexual dimorphism in 11 β hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects , 1998, Clinical endocrinology.
[150] J. Seckl,et al. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. , 2004, Endocrinology.
[151] M. Hewison,et al. Differentiation of Adipose Stromal Cells: The Roles of Glucocorticoids and 11β-Hydroxysteroid Dehydrogenase. , 1999, Endocrinology.
[152] H. Bradlow,et al. Renal capture and oxidation of cortisol in man. , 1971, The Journal of clinical endocrinology and metabolism.
[153] E. Maser,et al. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1996, European journal of biochemistry.
[154] E. Maser. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes. , 1998, Cancer research.
[155] L. Myatt,et al. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts. , 2003, Endocrinology.
[156] H. Bradlow,et al. Metabolic transformation of hydrocortisone-4-C14 in normal men. , 1960, The Journal of biological chemistry.
[157] J. Ozols. Lumenal Orientation and Post-translational Modifications of the Liver Microsomal 11-Hydroxysteroid Dehydrogenase (*) , 1995, The Journal of Biological Chemistry.
[158] D. Carmelli,et al. Evidence for independent genetic influences on obesity in middle age. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[159] M. Kilby,et al. Expression of 11 beta-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies. , 2001, Molecular human reproduction.
[160] J. Seckl,et al. Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[161] E. Maser,et al. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. , 1994, Biochemical pharmacology.
[162] C. Lockwood,et al. Expression of 11 beta-hydroxysteroid dehydrogenase during decidualization of human endometrial stromal cells. , 1996, Endocrinology.
[163] Z. Krozowski,et al. Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme , 1994, Molecular and Cellular Endocrinology.
[164] K. Boelaert,et al. Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation , 2003, Oncogene.
[165] P. White,et al. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. , 1993 .
[166] R. Benediktsson,et al. 11 beta-Hydroxysteroid dehydrogenase in the rat ovary: high expression in the oocyte. , 1992, The Journal of endocrinology.
[167] H. Morita,et al. 11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone. , 1996, Endocrinology.
[168] K. Hierholzer,et al. Immunohistochemical localization of 11-hydroxysteroid dehydrogenase in rat kidney with monoclonal antibody. , 1989, Renal physiology and biochemistry.
[169] B. Waddell,et al. Interconversion of cortisol and cortisone in the baboon placenta at midgestation: Expression of 11β-hydroxysteroid dehydrogenase type 1 messenger RNA , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[170] M. Hewison,et al. Regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. , 1998, The Journal of endocrinology.
[171] R. Cortese,et al. Corrigendum: Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice (The Embo Journal (1995) 14 (1932-1941)) , 1995 .
[172] M E Baker,et al. Structures stabilizing the dimer interface on human 11 beta-hydroxysteroid dehydrogenase types 1 and 2 and human 15-hydroxyprostaglandin dehydrogenase and their homologs. , 1995, Biochemical and biophysical research communications.
[173] W. S. Lee,et al. Aberrant 11beta-hydroxysteroid dehydrogenase-1 activity in the cpk mouse: implications for regulation by the Ke 6 gene. , 1996, Endocrinology.
[174] R. Kozera,et al. Plasma cortisone concentration as measured by radioimmunoassay. , 1973, The Journal of clinical endocrinology and metabolism.
[175] N. Crabtree,et al. Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity. , 2003, The Journal of clinical endocrinology and metabolism.
[176] R. Jaenisch,et al. Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? , 1989, Genes & development.
[177] G. Fink,et al. Use of in situ hybridization to investigate the regulation of hippocampal corticosteroid receptors by monoamines , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[178] G. Tomkins,et al. The multiplicity and specificity of δ4-3-ketosteroid hydrogenases (5α) , 1959 .
[179] R. Smith,et al. Tissue-specific expression of an 11 beta-hydroxysteroid dehydrogenase with a truncated N-terminal domain. A potential mechanism for differential intracellular localization within mineralocorticoid target cells. , 1992, The Journal of biological chemistry.
[180] D. Ghosh,et al. The fascinating complexities of steroid-binding enzymes. , 1996, Current opinion in structural biology.
[181] A. Blum,et al. Human 11beta-hydroxysteroid dehydrogenase type 1 is enzymatically active in its nonglycosylated form. , 2000, Biochemical and biophysical research communications.
[182] M. Alessi,et al. Expression of the mRNA Coding for 11-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Patients : An in Situ Hybridization Study , 2002 .
[183] B. Walker,et al. Increased cortisol: cortisone ratio in acute pulmonary tuberculosis. , 2000, American journal of respiratory and critical care medicine.
[184] J. Funder,et al. The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies. , 1989, Endocrinology.
[185] J. Tait,et al. Aldosterone secretion and metabolism in normal men and women and in pregnancy. , 1959, Acta endocrinologica.
[186] M. Garabedian,et al. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms , 1997, Molecular and cellular biology.
[187] C. Monder,et al. Evidence for kinetically distinct forms of corticosteroid 11 beta-dehydrogenase in rat liver microsomes. , 1989, Journal of steroid biochemistry.
[188] L. Wall,et al. CAAT/Enhancer-binding Proteins Are Involved in β-Globin Gene Expression and Are Differentially Expressed in Murine Erythroleukemia and K562 Cells* , 1996, The Journal of Biological Chemistry.
[189] C. Edwards,et al. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man. , 1990, Clinical science.
[190] M. Cooper,et al. Expression of 11β‐hydroxysteroid dehydrogenase in rat osteoblastic cells: Pre‐receptor regulation of glucocorticoid responses in bone , 2001, Journal of cellular biochemistry.
[191] C. Monder,et al. Inhibition by glycyrrhetinic acid of rat tissue 11β-hydroxysteroid dehydrogenase in vivo , 1993, Steroids.
[192] B. Wermuth,et al. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. , 1989, The Journal of biological chemistry.
[193] M. Hardy,et al. The functional roles of 11β-HSD1: vascular tissue, testis and brain , 2003, Molecular and Cellular Endocrinology.
[194] J. Challis,et al. Developmental and glucocorticoid regulation of pituitary 11 beta-hydroxysteroid dehydrogenase 1 gene expression in the ovine fetus and lamb. , 1995, Journal of molecular endocrinology.
[195] P. Stewart,et al. Tissue specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase gene expression , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[196] R. Daynes,et al. 11 beta-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. , 1996, The American journal of physiology.
[197] Y. Kallberg,et al. Coenzyme-based functional assignments of short-chain dehydrogenases/reductases (SDRs). , 2003, Chemico-biological interactions.
[198] B. Persson,et al. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes. , 1997, European journal of biochemistry.
[199] J. Mason,et al. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. , 1994, The Journal of clinical endocrinology and metabolism.
[200] J. Connell,et al. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. , 1999, Hypertension.
[201] S. Hillier,et al. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 gene expression in human ovarian surface epithelial cells by interleukin-1. , 2002, Human reproduction.
[202] M. Taniyama,et al. Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: application for diagnosis of resistance to thyroid hormone. , 1993, Thyroid : official journal of the American Thyroid Association.
[203] G. Fink,et al. The 11 beta-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats. , 1993, The Journal of endocrinology.
[204] M Krook,et al. Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.
[205] J. Macdonald,et al. Prostaglandin F2 Potentiates Cortisol Production by Stimulating 11 -Hydroxysteroid Dehydrogenase 1: A Novel Feedback Loop That May Contribute to Human Labor , 2001 .
[206] M. Cooper,et al. Regulation of Expression of 11b-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue: Tissue-Specific Induction by Cytokines* , 2001 .
[207] T. Nonaka,et al. Crystal structures of the binary and ternary complexes of 7 alpha-hydroxysteroid dehydrogenase from Escherichia coli. , 1996, Biochemistry.
[208] B. Strutt,et al. Insulin attenuates the stimulatory effects of tumor necrosis factor α on 11β-hydroxysteroid dehydrogenase 1 in human adipose stromal cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[209] P. Stewart,et al. Epithelial cell localization of type 2 11 beta-hydroxysteroid dehydrogenase in rat and human colon. , 1994, Endocrinology.
[210] C. Edwards,et al. Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[211] P. Stewart,et al. Ontogeny and sexual dimorphic expression of mouse type 2 11β-hydroxysteroid dehydrogenase , 1997, Molecular and Cellular Endocrinology.
[212] P. Stewart,et al. Does central obesity reflect “Cushing's disease of the omentum”? , 1997, The Lancet.
[213] D. Morris,et al. 11β-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism , 2002, Steroids.
[214] H. Bradlow,et al. Influence of thyroid function on the in vivo cortisol in equilibrium cortisone equilibrium in man. , 1983, Journal of steroid biochemistry.
[215] J. Challis,et al. Differential Regulation of 11 β-Hydroxysteroid Dehydrogenase Type 1 and 2 by Nitric Oxide in Cultured Human Placental Trophoblast and Chorionic Cell Preparation. , 1997, Endocrinology.
[216] P. Stewart,et al. MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY COMES OF AGE , 1987, The Lancet.
[217] John J. Mullins,et al. Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice* , 2001, The Journal of Biological Chemistry.
[218] P. White,et al. Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency , 1994, Pediatric Nephrology.
[219] S. Coppack,et al. An in vivo study of the cortisol–cortisone shuttle in subcutaneous abdominal adipose tissue , 1999, Clinical endocrinology.
[220] B. Persson,et al. Medium-chain dehydrogenases/reductases (MDR). Family characterizations including genome comparisons and active site modeling. , 2002, European journal of biochemistry.
[221] L. Sreerama,et al. Identification of the class-3 aldehyde dehydrogenases present in human MCF-7/0 breast adenocarcinoma cells and normal human breast tissue. , 1994, Biochemical pharmacology.
[222] C. Edwards,et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid , 1990, The Lancet.
[223] P. Strippoli,et al. LACK OF MUTATIONS OF TYPE 1 11β-HYDROXYSTEROID DEHYDROGENASE GENE IN PATIENTS WITH ABDOMINAL OBESITY , 2001, Endocrine research.
[224] K. Yang,et al. Guinea pig 11β-hydroxysteroid dehydrogenase type 1: primary structure and catalytic properties☆ , 2000, Steroids.
[225] G. Firestone,et al. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[226] B. Walker,et al. 11 beta-hydroxysteroid dehydrogenase type 1 is a predominant 11 beta-reductase in the intact perfused rat liver. , 2000, The Journal of endocrinology.
[227] A. Howie,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Expression of Type 2 11�-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life* , 2022 .
[228] H. Riechelmann,et al. 11Beta-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck. , 2002, Clinical otolaryngology and allied sciences.
[229] A. Tanswell,et al. Influence of corticosteroids on glycogen content and steroid 11-reductase activity in lung and liver of the fetal and newborn rat. , 1982, Biology of the neonate.
[230] Xiao Hong Ma,et al. Gestation-related and betamethasone-induced changes in 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta. , 2003, American journal of obstetrics and gynecology.
[231] J. Jenkins,et al. Periovulatory human oocytes, cumulus cells, and ovarian leukocytes express type 1 but not type 2 11beta-hydroxysteroid dehydrogenase RNA. , 2000, Fertility and sterility.
[232] H. Bradlow,et al. Cortoic acids: explorations at the frontier of corticosteroid metabolism. , 1980, Recent progress in hormone research.
[233] L. Campbell,et al. Cellular localization and developmental regulation of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) gene expression in the ovine placenta , 1997 .
[234] A. Odermatt,et al. The N-terminal Anchor Sequences of 11β-Hydroxysteroid Dehydrogenases Determine Their Orientation in the Endoplasmic Reticulum Membrane* , 1999, The Journal of Biological Chemistry.
[235] E. Hodgson,et al. Mouse liver microsomal hexose-6-phosphate dehydrogenase. NADPH generation and utilization in monooxygenation reactions. , 1982, Biochemical pharmacology.
[236] P. Lichter. Genetic clues to glaucoma's secrets. The L Edward Jackson Memorial Lecture. Part 2. , 1994, American journal of ophthalmology.
[237] S. Wright,et al. 11β-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages1 , 2001, The Journal of Immunology.
[238] C. Shackleton,et al. Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man , 1996, Clinical endocrinology.
[239] Edwards,et al. 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress , 1997 .
[240] C. Wood,et al. Characterization of 11 beta-hydroxysteroid dehydrogenase activity in fetal and adult ovine tissues. , 1995, Reproduction, fertility, and development.
[241] J. Ott,et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q , 1998, European Journal of Human Genetics.
[242] V. Poli,et al. C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. , 2000, The Journal of biological chemistry.
[243] J. Jenkins,et al. The detection and confirmation of 11 beta-hydroxysteroid dehydrogenase type 1 transcripts in human luteinized granulosa cells using RT-PCR and plasmid pUC18. , 1997, Molecular human reproduction.
[244] C. Edwards,et al. Rat liver 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. , 1993, Endocrinology.
[245] S. H. Hori,et al. Differential effects of the NADPH/NADP+ ratio on the activities of hexose-6-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase. , 1981, Biochimica et biophysica acta.
[246] N. Golestaneh,et al. Mineralocorticoid Hormone Signaling Regulates the ‘Epithelial Sodium Channel’ in Fibroblasts from Human Cornea , 2000, Ophthalmic Research.
[247] B. Waddell,et al. Localization of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 in the Male Reproductive Tract , 2003 .
[248] P. Osinski,et al. Steroid 11β-ol Dehydrogenase in Human Placenta , 1960, Nature.
[249] J. Connell,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Apparent Cortisone Reductase Deficiency: A Functional Defect in 11�-Hydroxysteroid Dehydrogenase Type 1* , 2022 .
[250] W. Miller,et al. Structure and function of the hepatic form of 11 beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. , 1993, Endocrinology.
[251] J. Seckl,et al. 11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[252] M. Hardy,et al. Protein Kinase C Increases 11β‐Hydroxysteroid Dehydrogenase Oxidation and Inhibits Reduction in Rat Leydig Cells , 2002 .
[253] D. Webb,et al. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. , 1992, Clinical science.
[254] L. M. Thurston,et al. Ovarian modulators of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity in follicular fluid from gonadotrophin-stimulated assisted conception cycles. , 2002, Reproduction.
[255] B. Walker,et al. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. , 2002, The Journal of clinical endocrinology and metabolism.
[256] Shalet,et al. Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent , 2000, Clinical endocrinology.
[257] D. Morris,et al. Bidirectional activity of 11β-hydroxysteroid dehydrogenase in vascular smooth muscle cells , 1995, Steroids.
[258] R. Eastell,et al. 11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. , 2003, The Journal of clinical endocrinology and metabolism.
[259] F. Frey,et al. Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. , 1998, Gastroenterology.
[260] E. Papoutsakis,et al. Molecular characterization of two Clostridium acetobutylicum ATCC 824 butanol dehydrogenase isozyme genes , 1992, Journal of bacteriology.
[261] D. Webb,et al. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. , 1995, The Journal of clinical endocrinology and metabolism.
[262] A. Agarwal. TRANSCRIPTIONAL INFLUENCE OF TWO POLY PURINE-PYRIMIDINE TRACTS LOCATED IN THE HSD11B2 (11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2) GENE , 2001, Endocrine research.
[263] B. Walker,et al. Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity. , 2003, Endocrinology.
[264] C. Edwards,et al. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.
[265] T. Nonaka,et al. Roles of the Ser146, Tyr159, and Lys163 residues in the catalytic action of 7alpha-hydroxysteroid dehydrogenase from Escherichia coli. , 1998, Journal of biochemistry.
[266] D. Blanchard,et al. Reciprocal changes in plasma corticosterone and testosterone in stressed male rats maintained in a visible burrow system: evidence for a mediating role of testicular 11 beta-hydroxysteroid dehydrogenase. , 1994, Endocrinology.
[267] C. Edwards,et al. Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. , 1993, The Journal of endocrinology.
[268] C. Sweep,et al. Short‐term cortisol infusion in the brachial artery, with and without inhibiting 11β‐hydroxysteroid dehydrogenase, does not alter forearm vascular resistance in normotensive and hypertensive subjects , 2002, European journal of clinical investigation.
[269] T. Friedman,et al. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice. , 2003, Diabetes.
[270] V. Han,et al. Spatial and Temporal Patterns of Expression of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 Messenger RNA and Glucocorticoid Receptor Protein in the Murine Placenta and Uterus During Late Pregnancy1 , 2002, Biology of reproduction.
[271] P. White,et al. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. , 1991, The Journal of biological chemistry.
[272] C. Edwards,et al. Ovarian 11β-hydroxysteroid dehydrogenase: potential predictor of conception by in-vitro fertilisation and embryo transfer , 1993, The Lancet.
[273] B. Persson,et al. Dual relationships of xylitol and alcohol dehydrogenases in families of two protein types , 1993, FEBS letters.
[274] I. Robinson,et al. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. , 1994, The Journal of endocrinology.
[275] M. Abramovitz,et al. Cortisol-cortisone interconversion in human fetal lung: contrasting results using explant and monolayer cultures suggest that 11 beta-hydroxysteroid dehydrogenase (EC 1.1.1.146) comprises two enzymes. , 1982, The Journal of clinical endocrinology and metabolism.
[276] L. Abrahmsén,et al. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice , 2002, Diabetologia.
[277] H. Jörnvall,et al. Comparative Enzymology of 11β-Hydroxysteroid Dehydrogenase Type 1 from Glucocorticoid Resistant (Guinea Pig) Versus Sensitive (Human) Species* , 2003, The Journal of Biological Chemistry.
[278] B. Walker,et al. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. , 1991, Endocrinology.
[279] A. Blum,et al. Human 11β-hydroxysteroid dehydrogenase 1/carbonyl reductase : recombinant expression in the yeast Pichia pastoris and Escherichia coli , 2000 .
[280] Erik Nordling,et al. Short-chain dehydrogenases/reductases (SDR): the 2002 update. , 2003, Chemico-biological interactions.
[281] S. Matthews,et al. Differential expression of 11 beta-hydroxysteroid dehydrogenase 1 and 2 in the developing ovine fetal liver and kidney. , 1995, The Journal of endocrinology.
[282] E. Maser,et al. 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase. , 2002, Biochemistry.
[283] M. F. Armaly. Dexamethasone ocular hypertension and eosinopenia, and glucose tolerance test. , 1967, Archives of ophthalmology.
[284] C. Maser-Gluth,et al. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig. , 2003, The Journal of endocrinology.
[285] Y. J. Liu,et al. Effect of growth hormone, insulin and dexamethasone on 11 beta-hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes. , 1996, Life sciences.
[286] B. Walker,et al. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. , 2000, The Journal of endocrinology.
[287] G. Chrousos,et al. 11β-Hydroxysteroid dehydrogenase activity in hypothalamic obesity , 2003 .
[288] M. Hewison,et al. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. , 2002, The Journal of clinical endocrinology and metabolism.
[289] J. Givens. Familial polycystic ovarian disease. , 1988, Endocrinology and metabolism clinics of North America.
[290] J. Seckl,et al. Distinct Ontogeny of Glucocorticoid and Mineralocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase Types I and II mRNAs in the Fetal Rat Brain Suggest a Complex Control of Glucocorticoid Actions , 1998, The Journal of Neuroscience.
[291] A. Bradley,et al. Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.
[292] H. Jörnvall,et al. Type 1 11β-Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets* , 2000, The Journal of Biological Chemistry.
[293] C. Shackleton. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[294] R. E. Peterson,et al. The metabolism of corticosterone in man. , 1960, The Journal of clinical investigation.
[295] Z. Krozowski. The short-chain alcohol dehydrogenase superfamily: Variations on a common theme , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[296] A. Nordenström,et al. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity. , 1999, The Journal of clinical endocrinology and metabolism.
[297] A. Hsueh,et al. Glucocorticoid inhibition of fsh-induced estrogen production in cultured rat granulosa cells , 1978, Steroids.
[298] M. Cooper,et al. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. , 2000, Bone.
[299] P. Meulenberg,et al. The effect of oral contraceptive use and pregnancy on the daily rhythm of cortisol and cortisone. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[300] L. Abrahmsén,et al. Purification of full-length recombinant human and rat type 1 11beta-hydroxysteroid dehydrogenases with retained oxidoreductase activities. , 2002, Protein expression and purification.
[301] C. Edwards,et al. 11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism. , 1996, The Biochemical journal.
[302] Y. Takeda,et al. 11β-Hydroxysteroid dehydrogenaseとステロイド受容体 , 1992 .
[303] W. Mercer,et al. Characterization of 11β-HSD1B gene expression and enzymatic activity , 1993, Molecular and Cellular Endocrinology.
[304] B. Persson,et al. Medium‐chain dehydrogenases/reductases (MDR) , 2002 .
[305] D. Driscoll,et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[306] M. Cooper,et al. Modulation of 11β‐Hydroxysteroid Dehydrogenase Isozymes by Proinflammatory Cytokines in Osteoblasts: An Autocrine Switch from Glucocorticoid Inactivation to Activation , 2001 .
[307] G. Kaltsas,et al. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. , 1999, The Journal of clinical endocrinology and metabolism.
[308] B. Walker,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Development-Related Increase in Cortisol Biosynthesis , 2022 .
[309] U. Oppermann,et al. Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. , 2000, Toxicology.
[310] U. Oppermann,et al. Cloning and primary structure of murine 11 beta-hydroxysteroid dehydrogenase/microsomal carbonyl reductase. , 1995, European journal of biochemistry.
[311] A. Payne,et al. Multiple mechanisms for regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5----delta 4-isomerase, 17 alpha-hydroxylase/C17-20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells. , 1991, Endocrinology.
[312] B. Murphy. Specificity of human 11β-hydroxysteroid dehydrogenase , 1981 .
[313] Erik Nordling,et al. Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases* , 2002, The Journal of Biological Chemistry.
[314] J. Whitworth,et al. Glucocorticoids and hypertension in man. , 1997, Clinical and experimental hypertension.
[315] L. Beckman,et al. Heterozygosity effects in studies of genetic markers and disease. , 1990, Human heredity.
[316] P. White,et al. Prominent sex steroid metabolism in human lymphocytes , 1998, Molecular and Cellular Endocrinology.
[317] G. Simpson,et al. Regulation of 11 (cid:1) -hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-1 (cid:1) in cultured rat granulosa cells , 1999 .
[318] J. Bunt,et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. , 2003, The Journal of clinical endocrinology and metabolism.
[319] A. Atalla,et al. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung. , 2001, Chemico-biological interactions.
[320] D. Morris,et al. Localization of 2 11β-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells , 1998 .
[321] P. Stewart,et al. 11β-Hydroxysteroid dehydrogenase in the rat adrenal , 1996 .
[322] B. Strutt,et al. 11β-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: Effect on aromatase activity , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[323] R. Daynes,et al. Active catabolism of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase in vivo is a necessary requirement for natural resistance to infection with Listeria monocytogenes. , 1997, International immunology.
[324] P. Stewart,et al. Localization of renal 11 beta-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor. , 1991, Endocrinology.
[325] K. Hierholzer,et al. Endogenous inhibitors of 11β-OHSD: Existence and possible significance , 1994, Steroids.
[326] C. Edwards,et al. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. , 1990, Endocrinology.
[327] R. Weinreb,et al. Detection of glucocorticoid receptors in cultured human trabecular cells. , 1981, Investigative ophthalmology & visual science.
[328] M. Hughson,et al. Regulation of 11 beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. , 2003, American journal of physiology. Endocrinology and metabolism.
[329] M. Cooper,et al. Osteoblastic 11β‐Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[330] G. Chrousos,et al. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. , 2003, The Journal of clinical endocrinology and metabolism.
[331] L. Campbell,et al. Pattern of 11 beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in the ovine uterus during the estrous cycle and pregnancy. , 1996, Biology of reproduction.
[332] Takashi Suzuki,et al. Immunohistochemical distribution of 11β-hydroxysteroid dehydrogenase in human eye , 2001, Molecular and Cellular Endocrinology.
[333] Z. Hochberg,et al. Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition , 2003, International Journal of Obesity.
[334] C. Pavlides,et al. 11β-Hydroxysteroid dehydrogenase functions reversibly as an oxidoreductase in the rat hippocampus in vivo , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[335] J. Seckl,et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[336] G. Korza,et al. Targeting Proteins to the Lumen of Endoplasmic Reticulum Using N-terminal Domains of 11β-Hydroxysteroid Dehydrogenase and the 50-kDa Esterase* , 1999, The Journal of Biological Chemistry.
[337] D. Marver. Evidence of corticosteroid action along the nephron. , 1984, The American journal of physiology.
[338] J. Challis,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Differential Expression of 11�-Hydroxysteroid Dehydrogenase Types 1 and 2 in Human Placenta and Fetal Membranes* , 2022 .
[339] R. Dilley,et al. Light and Electron Microscopy Localization of the 11β-Hydroxysteroid Dehydrogenase Type I Enzyme in the Rat. , 2001, Endocrinology.
[340] P. Burra,et al. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. , 1993, The Journal of clinical endocrinology and metabolism.
[341] W. Budde. Heredity in primary open-angle glaucoma. , 2000, Current opinion in ophthalmology.
[342] M. Hardy,et al. Expression of 11-hydroxylase in Rat Leydig Cells , 2022 .
[343] J. Funder,et al. Epithelial and adipose cells isolated from mammary glands of pregnant and lactating rats differ in 11β-hydroxysteroid dehydrogenase activity , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[344] M. Hardy,et al. Hormonal Regulation of Oxidative and Reductive Activities of 11β-Hydroxysteroid Dehydrogenase in Rat Leydig Cells1. , 1997, Endocrinology.
[345] B. Persson,et al. The 11β‐Hydroxysteroid Dehydrogenase System, A Determinant of Glucocorticoid and Mineralocorticoid Action , 1997 .
[346] P. Siiteri,et al. Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. , 1991, The Journal of clinical endocrinology and metabolism.
[347] A. Yergey,et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. , 1991, The Journal of clinical endocrinology and metabolism.
[348] H. Jörnvall,et al. Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1. , 2001, Chemico-biological interactions.
[349] C. G. Bellows,et al. Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differ in their response to corticosterone, cortisol, and cortisone. , 1998, Bone.
[350] C. O'brien,et al. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues. , 2000, Investigative ophthalmology & visual science.
[351] A. Aguzzi,et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. , 1995, Genes & development.
[352] T. Vulliamy,et al. Human hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) encoded at 1p36: coding sequence and expression. , 1999, Blood cells, molecules & diseases.
[353] B. Walker,et al. Obesity and gender influence cortisol secretion and metabolism in man. , 1998, The Journal of clinical endocrinology and metabolism.
[354] L. Abrahmsén,et al. Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. , 2002, Journal of medicinal chemistry.
[355] A. Bossowski,et al. 11β-Hydroxysteroid Dehydrogenase Type 1 Deficiency (‘Apparent Cortisone Reductase Deficiency’) in a 6-Year-Old Boy , 2003, Hormone Research in Paediatrics.
[356] J. Macdonald,et al. Prostaglandin F2alpha potentiates cortisol production by stimulating 11beta-hydroxysteroid dehydrogenase 1: a novel feedback loop that may contribute to human labor. , 2001, The Journal of clinical endocrinology and metabolism.
[357] D. Phillips,et al. Corticosteroid 11β-Dehydrogenase in Rat Testis* , 1989 .
[358] D. Hardy,et al. Developmental Changes in Glucocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase Oxidative and Reductive Activities in Rat Leydig Cells. , 1997, Endocrinology.
[359] V. Pletnev,et al. Steroid dehydrogenase structures, mechanism of action, and disease. , 2000, Vitamins and hormones.
[360] I. Stupans,et al. Absence of type 1 11beta-hydroxysteroid dehydrogenase enzyme in koala liver. , 2002, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.
[361] T. Ebels,et al. LONG-TERM EVALUATION OF MECHANICAL HEART-VALVES - REPLY , 1989 .
[362] P. Stewart,et al. 11 beta-Hydroxysteroid dehydrogenase. , 1994, Vitamins and hormones.
[363] P. White,et al. Tyr-179 and Lys-183 are essential for enzymatic activity of 11 beta-hydroxysteroid dehydrogenase. , 1992, Biochemical and biophysical research communications.
[364] J. Hodges,et al. Modulation of plasminogen activation by glucocorticoid hormones in the rat granulosa cell. , 1987, The Journal of endocrinology.
[365] H. Jörnvall,et al. Forms and functions of human SDR enzymes. , 2001, Chemico-biological interactions.
[366] T. Deguchi,et al. ROLE OF LOCAL 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE 2 (HSD11B2) EXPRESSION IN DETERMINING THE PHENOTYPE OF ADRENAL ADENOMAS , 2002, Endocrine research.
[367] M. Tusié-Luna,et al. Expression of 11β-Hydroxysteroid Dehydrogenase Using Recombinant Vaccinia Virus , 1990 .
[368] C. Remacle,et al. Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors. , 1991, Experimental cell research.
[369] R. Meigs,et al. Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparations of liver. , 1968, The Biochemical journal.
[370] B. Mendonca,et al. Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome. , 1986, The Journal of pediatrics.
[371] M. Fromm,et al. Gestational age dependence of 11 beta-hydroxysteroid dehydrogenase and its relationship to the enzymes of phosphatidylcholine synthesis in lung and liver of fetal rat. , 1994, Biochimica et biophysica acta.
[372] G. Simpson,et al. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-1beta in cultured rat granulosa cells. , 1999, The Journal of endocrinology.
[373] T. Olsson,et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. , 2001, The Journal of clinical endocrinology and metabolism.
[374] F. Frey. Kinetics and dynamics of prednisolone. , 1987, Endocrine reviews.
[375] R. Smith,et al. Sex- and tissue- specific regulation of 11 beta-hydroxysteroid dehydrogenase mRNA. , 1995, Molecular and cellular endocrinology.
[376] E. Maser,et al. 11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone. , 2003, Chemico-biological interactions.
[377] J. Seckl,et al. 11beta-hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells. , 1998, The Journal of endocrinology.
[378] M. Hardy,et al. Mechanisms of glucocorticoid-induced Leydig cell apoptosis , 2003, Molecular and Cellular Endocrinology.
[379] K. Noonan,et al. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults , 1994, Clinical endocrinology.
[380] V. Han,et al. Identification and tissue distribution of a novel variant of 11β-hydroxysteroid dehydrogenase 1 transcript , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[381] D. Morris,et al. Effects of licorice derivatives on vascular smooth muscle function. , 1996, Life sciences.
[382] E. Albrecht,et al. Expression of the 11beta-hydroxysteroid dehydrogenase types 1 and 2 proteins in human and baboon placental syncytiotrophoblast. , 1999, Placenta.
[383] C. Monder,et al. Corticosteroid llβ-Dehydrogenase of Rat Tissues: Immunological Studies , 1990 .
[384] T. Olsson,et al. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. , 2003, The Journal of clinical endocrinology and metabolism.
[385] B. Cooke,et al. The effects of different culture media, glucose, pyridine nucleotides and adenosine on the activity of 11β-hydroxysteroid dehydrogenase in rat Leydig cells , 1999, Molecular and Cellular Endocrinology.
[386] Mason,et al. Corticosteroid metabolism in human granulosa‐lutein cells , 1998, Clinical endocrinology.
[387] A. Náray-Fejes-Tóth,et al. The ups and downs of glucocorticoid physiology Permissive and suppressive effects revisited , 1992, Molecular and Cellular Endocrinology.
[388] Ľ. Stárka,et al. Steroids and intraocular pressure. , 1976, Journal of steroid biochemistry.
[389] J. Dowling,et al. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. , 1995, The Journal of clinical endocrinology and metabolism.
[390] E. Snyder,et al. The human obesity gene map: the 2001 update. , 2002, Obesity research.
[391] H. Jörnvall,et al. Selective inhibition of human type 1 11β‐hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics , 1998, FEBS letters.